Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Contrast Media × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Glioma 2 Glioblastoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Ductal Adenocarcinoma 1 Osteoradionecrosis 1 Mouth Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Hematopoietic and Lymphoid System Neoplasm 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Ependymoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Bevacizumab 59 atezolizumab 51 durvalumab 37 lenvatinib 35 pembrolizumab 33 Nivolumab 28 tremelimumab 23 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Sorafenib 16 Ipilimumab 13 tislelizumab 12 regorafenib 12 cabozantinib 12 apatinib 11 Radiosurgery 11 Immune Checkpoint Inhibitors 11 sintilimab 10 camrelizumab 9 Blood Specimen Collection 9 Radiotherapy 8 Immunoglobulin G 7 Cyclophosphamide 7 X-Rays 6 Hepatectomy 6 Disulfides 6 donafenib 5 Surgical Procedures, Operative 5 Fluorouracil 5 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡